6 verified backers on Dualitas Therapeutics's cap table, including Versant Ventures, Qiming Venture Partners USA.
Dualitas Therapeutics's investor syndicate for 2026, drawn from verified round records: 6 distinct firms and angels appear on the cap table, including Versant Ventures, Qiming Venture Partners USA, SV Health Investors, Chugai Venture Fund, Eli Lilly and Company, Alexandria Venture Investments. Dualitas Therapeutics is tracked in Biotech and headquartered in South San Francisco, United States.
The companies listed below are ranked by how much of that syndicate they share, so the overlap you see is backer-based rather than sector-based. Every investor name links to that firm's own profile with its full tracked portfolio, and every company links to its funding record.
Dualitas Therapeutics funding profile · All research reports